2013 American Transplant Congress
Liver Transplant (OLT) Length of Stay (LOS) 2000-2010: An Analysis of the UNOS/OPTN Database
General Surgery, Cleveland Clinic, Cleveland, OH
Aim: To define regional patterns in post OLT LOS.Methods: Using the UNOS database (06/2011) we reviewed data on 65,891 OLT recipients, 01/2000-12/2010. Patients excluded (n=11,784)…2013 American Transplant Congress
Kidney Transplant Outcomes by Living Donor (LD) Relationship
From 2007 to 2011, the proportion of LDs from paired kidney donor (PKD) programs tripled (3.5%-10.8%) and from non-directed donors (NDD) doubled (1.3%-2.6%). As these…2013 American Transplant Congress
Status 1A Utilization for Heart Transplant Candidates with Ventricular Assist Devices (VADs)
Background: OPTN policy 3.7.3(a)(i) allows heart transplant candidates with ventricular assist devices (VAD) to be listed as Status 1A for 30 days at any time…2013 American Transplant Congress
Surgical Complication Rates in Patients Receiving Kidney Transplants in England: Analysis by Transplant Centre Using Linked Registry and Hospitalisation Data
Introduction: Previous UK studies have found similar centre-specific graft and patient survival following first transplantation, however other measures of surgical performance have not previously been…2013 American Transplant Congress
Belimumab (Anti-BAFF/BLyS) Effective in a Case of Resistant Antibody Mediated Rejection
Division of Nephrology, University of Washington, Seattle, WA
PURPOSE: Belimumab is a humanized IgG1 monoclonal antibody to B-cell activating factor (BAFF), also known as B-lymphocyte Stimulator (BLyS). BAFF works through three receptors to…2013 American Transplant Congress
Improving the SRTR Methodology Used To Identify Potentially Underperforming Transplant Programs in the United States
In Feb. 2012, SRTR and OPTN jointly hosted a consensus conference on transplant program quality and surveillance. One recommendation was to study Bayesian hierarchical modeling…2013 American Transplant Congress
Early and Late Reuse of Liver Allografts from Brain-Dead Liver Transplant Recipients
Transplant Surgery, Medstar Georgetown transplant Institute, Washington, DC
A unique method of donor pool expansion is the retransplantation of livers from recipients who die (brain-death). The hesitancy to reuse livers is in part…2013 American Transplant Congress
Efficacy and Safety of Single Fixed-Dose Rituximab for Recurrent Glomerulonephritis Post-Transplantation
Barnes-Jewish Hospital, St. Louis, MO; Washington University School of Medicine, St. Louis, MO
Purpose: Rituximab, using a multi-dose regimen based on body surface area, has been used for recurrent glomerulonephritis (GN) post-renal transplant with variable success. We examined…2013 American Transplant Congress
Has the VA Found a Way To Reduce Racial Disparities in Kidney Transplant Evaluation? Preliminary Results from the National VA Kidney Transplant Study
End-stage kidney disease is more common in African Americans (AA) and other minorities (OM) (e.g., Hispanic/Latinos) than Whites (WH). Reports from national data indicate that…2013 American Transplant Congress
Impact of Induction Therapy on Clinical Outcomes and Quality of Life in Aged Kidney Transplant Recipients, The
Division of Transplant Surgery, MUSC, Charleston, SC; Dept of Pharmacy, MUSC, Charleston, SC
Background: In older renal transplant recipients, where death with functioning graft limits life years gained, one of the primary purposes of transplant is to improve…
- « Previous Page
- 1
- …
- 150
- 151
- 152
- 153
- 154
- …
- 178
- Next Page »